IP Library Patent Application 11707220
Patent Application
App. No. 11/707,220

Methods of detecting a target nucleic acid

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/707,220
Abstract

The invention relates to compositions and methods of generating a signal indicative of the presence of a target nucleic acid in a sample, where the method includes forming a cleavage structure by incubating a sample comprising a target nucleic acid with a probe. The invention also includes the steps of cleaving the cleavage structure with a nuclease to release a nucleic acid fragment to generate a signal, wherein generation of the signal is indicative of the presence of a target nucleic acid in a sample.

Claims (22)

1 - 48 . (canceled)

49 . A method for detecting a target nucleic acid comprising: exposing a composition comprising a purified thermostable FEN-1 endonuclease and a purified nucleic acid molecule to a sample suspected of containing a target nucleic under conditions such that said target nucleic acid, if present in said sample, is detected.

50 . The method of claim 49 , wherein said thermostable FEN-1 endonuclease comprises an FEN-1 endonuclease from an archaebacterial species.

51 . The method of claim 50 , wherein said FEN-1 endonuclease comprises a FEN-1 endonuclease from Pyrococcus furiosus.

52 . The method of claim 49 , further comprising a polymerase.

53 . The method of claim 52 , wherein said polymerase comprises a thermostable polymerase.

54 . The method of claim 52 , wherein said polymerase comprises a template-dependent polymerase.

55 . The method of claim 49 , wherein said purified thermostable FEN-1 endonuclease and said purified nucleic acid molecule are in a mixture.

56 . The method of claim 55 , wherein said mixture comprises a reaction mixture.

57 . The method of claim 49 , wherein said exposing comprises hybridizing a second nucleic acid molecule to said target nucleic acid.

58 . The method of claim 57 , wherein said second nucleic acid molecule comprises a probe oligonucleotide.

59 . The method of claim 57 , wherein said second nucleic acid molecule comprises a label.

60 . The method of claim 59 , wherein said label comprises a fluorescent label.

61 . The method of claim 57 , wherein said exposing comprises hybridizing said purified nucleic acid molecule and said second nucleic acid molecule to said target nucleic acid.

62 . The method of claim 49 , wherein said detecting comprises detecting a non-target cleavage product.

63 . The method of claim 49 , wherein said detecting the cleavage of said cleavage structure comprises detection selected from the group consisting of detection of radioactivity, luminescence, phosphorescence, and fluorescence polarization.

64 . The method of claim 49 , wherein said detecting the cleavage of said cleavage structure comprises detection based on the charge of non-target cleavage product.

65 . The method of claim 49 , wherein said target nucleic acid is DNA.

66 . The method of claim 49 , wherein said target nucleic acid is synthetic nucleic acid.

67 . The method of claim 66 , wherein said synthetic nucleic acid comprises amplified nucleic acid.

68 . The method of claim 67 , wherein said synthetic nucleic acid is generated by a polymerase chain reaction.

69 . The method of claim 49 , wherein said target nucleic acid is RNA.

Assignments (4)
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
EIGHTH SUPPLEMENT TO PATENT SECURITY AGREEMENT Recorded Mar 26, 2009
From: CYTYC CORPORATION; HOLOGIC, INC.
To: GOLDMAN SACHS CREDIT PARTNERSL.P.
Reel/Frame 022456/0947 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2008
From: STRATAGENE CALIFORNIA
To: HOLOGIC INC.
Reel/Frame 021976/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2007
From: SORGE, JOSEPH A.
To: STRATAGENE CALIFORNIA
Reel/Frame 019418/0535 →